UCR Startup Receives $2.25 Million to Test New Cancer Drug
Riverside company's treatment targets aggressive tumors including pancreatic cancer.
Part 6 of Mangaka Sebraé Harris' Citrus Bellé comic series.
Let us email you Riverside's news and events every morning. For free!